DEF: Mistras Group Announces 2025 Annual Shareholders Meeting and Proxy Statement Details

Sentiment:

Proxy Statement


Mistras Group, Inc. is set to hold its 2025 Annual Shareholders Meeting virtually on May 19, 2025, with shareholders voting on director elections, auditor ratification, and executive compensation.

Worse than expectedThe company performed below target for Adjusted EBITDA and below the minimum threshold for revenue and free cash flow in 2024.

Summary

  • Mistras Group, Inc. will hold its 2025 Annual Shareholders Meeting on May 19, 2025, at 11:00 a.m. Eastern Time, conducted virtually via webcast.
  • Shareholders of record as of March 24, 2025, are entitled to vote on the election of seven directors, ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the year ending December 31, 2025, and an advisory vote on executive compensation.
  • The Board recommends voting FOR all director nominees, FOR the ratification of PricewaterhouseCoopers LLP, and FOR the advisory vote on executive compensation.
  • In 2024, the company's performance metrics for executive compensation included 60% Adjusted EBITDA, 25% revenue, and 15% free cash flow.
  • Due to the company performing below target for Adjusted EBITDA and below the minimum threshold for revenue and free cash flow, named executive officers earned 31.5% of their target incentive awards for 2024.
  • The Compensation Committee awarded Manny Stamatakis an option to purchase 375,000 shares of the company's common stock at an exercise price of $9.06 per share, vesting on January 6, 2026.
  • For 2025, Manny Stamatakis's annual salary as Executive Chairman is $725,000, and Natalia Shuman's salary as President and CEO is $850,000.
  • The company's peer group for benchmarking compensation includes companies like Archrock, Inc., CECO Environmental Corp., and CIRCOR International, Inc.

Sentiment

Score: 6

Explanation: The document is primarily factual and procedural, outlining the details of the upcoming shareholder meeting and executive compensation. While there are some negative aspects related to the company's performance against targets, the overall tone is neutral and focused on governance and compliance.

Positives

  • The Board is committed to maintaining good corporate governance practices.
  • The Board has separated the roles of Chairman and CEO.
  • The Board has adopted stock ownership guidelines for all directors and executive officers.
  • The Board has adopted an Incentive Compensation Recoupment Policy (often referred to as a claw-back policy).

Negatives

  • The company performed below target for Adjusted EBITDA and below the minimum threshold for revenue and free cash flow in 2024, resulting in lower incentive payouts for executives.
  • One report for a stock award was delinquent for each director and executive officer (except Ms. Shuman), one report of a sale by Richard Glanton and one report of a gift by Sotirios Vahaviolos.

Risks

  • The document mentions risks and exposures associated with financial matters, compliance, and information technology, data and cyber security.
  • The document mentions risks and exposures associated with management development, and executive compensation programs and arrangements, including performance-based incentive plans.
  • The document mentions risks and exposures associated with our activities as a corporate citizen and policies in that regard, our activities pertaining to environmental matters and sustainability, and activities, policies and practices pertaining to employee and workplace safety.

Future Outlook

The company's incentive compensation programs for named executives will remain substantially the same for 2025, except that the threshold to receive any payout related to the Adjusted EBITDA award has been increased from 90% to 95% of target.

Management Comments

  • The Board believes that overseeing how management manages the various risks the Company faces is one of its important responsibilities.
  • The Board believes that a director should be evaluated based upon his or her abilities and contributions to the Board and an assessment of that individuals qualities and qualifications to continue to serve as a director on the Board.

Industry Context

The document references companies involved in asset protection, testing, inspection, or similar industrial business services as part of its compensation peer group, indicating Mistras Group operates within the testing, inspection, and certification (TIC) industry.

Comparison to Industry Standards

  • The compensation peer group includes companies like Archrock, Inc., CECO Environmental Corp., CIRCOR International, Inc., Columbus McKinnon Corporation, and others, suggesting Mistras Group benchmarks its compensation against similar-sized firms in related industries.
  • The document mentions Eurofins Scientific Group and Bureau Veritas as leaders in the TIC industry, where Natalia Shuman previously held executive roles.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
President and Chief Executive OfficerManny Stamatakis (Interim)Natalia ShumanJanuary 1, 2025Appointment of permanent CEO
Executive ChairmanN/AManny StamatakisJanuary 1, 2025Transition from Interim President and CEO
Chief Operating OfficerN/AHani HammadJanuary 1, 2025Promotion from Chief Transformation Officer

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board CompositionElection of seven directors at the 2025 Annual Meeting.May 19, 2025Ensures continuity and oversight of company strategy and operations.
Auditor RatificationRatification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2025.December 31, 2025Maintains independent oversight of financial reporting.
Executive CompensationAdvisory vote on the compensation of Mistras Group, Inc.'s named executive officers.N/AProvides shareholders with a voice on executive pay practices.

Legal Proceedings

  • In October 2016, a company filed a lawsuit in Orange County, California Superior Court against one of our directors and a director nominee, Richard Glanton, along with a privately held company for which Mr. Glanton was a director and officer, and other parties for allegedly defaulting on loans, among other allegations.
  • In July 2017 and then in February 2022, Mr. Glanton filed separate voluntary proceedings under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of New Jersey.

Related Party Transactions

  • The company leases its headquarters from an entity majority-owned by Dr. Vahaviolos, with monthly payments of approximately $84,500 in 2024.
  • A subsidiary in Greece has an employment agreement with the daughter of Dr. Vahaviolos, who received approximately $136,000 in total compensation and benefits in 2024.
  • Another daughter of Dr. Vahaviolos is a Director of Benefits and Human Resource Information Systems in the U.S. and received total compensation in 2024 of approximately $249,000.
  • Manny Stamatakis, our Chairman and Interim President and CEO, is an officer of Capital Management Enterprise (CME) and was previously the owner of CME.

Stakeholder Impact

  • Shareholders are asked to vote on key governance matters, including director elections and executive compensation.
  • Employees are impacted by the company's compensation policies and performance-based incentives.
  • The company's performance and governance practices can affect its relationships with customers, suppliers, and creditors.

Next Steps

  • Shareholders are encouraged to vote and submit their proxy in advance of the annual meeting.
  • The Board and committees will continue to review committee charters and governance policies, guidelines, and practices annually.
  • The Compensation Committee will continue to review compensation practices and programs and consider changes as appropriate to meet compensation goals.

Key Dates

DateDescription
March 24, 2025Record date for determining shareholders entitled to vote at the 2025 Annual Meeting.
April 9, 2025Date of the Notice of Annual Meeting and Proxy Statement.
April 29, 2025Date before which shares of common stock may be acquired by an individual or group within 60 days of March 1, 2025 pursuant to the exercise of options or warrants, are deemed to be outstanding for the purpose of computing the percentage ownership of such individual or group.
May 14, 2025Date on which 125,000 restricted stock units (RSUs) awarded to Manny Stamatakis, then serving as our Chairman and Interim President and Chief Executive Officer, vest.
May 19, 2025Date of the 2025 Annual Shareholders Meeting.
January 2, 2026Deadline for submission of director candidates for consideration by the Corporate Governance Committee for the 2026 annual meeting.
January 6, 2026Date on which the option to purchase 375,000 shares of the Companys common stock at an exercise price of $9.06 per share, the closing price, as reported on the New York Stock Exchange on the grant date of January 6, 2025, will vest and become exercisable.
December 10, 2025Deadline for shareholder proposals to be included in the proxy statement for the 2026 annual shareholders meeting.
January 18, 2026Date on or after which a shareholder may nominate directors or have other business brought before the 2026 annual shareholders meeting.
February 17, 2026Date on or before which a shareholder may nominate directors or have other business brought before the 2026 annual shareholders meeting.
April 19, 2026Earliest date the 2026 shareholders meeting could be held.
July 18, 2026Latest date the 2026 shareholders meeting could be held.

Keywords

proxy statement, annual meeting, executive compensation, board of directors, corporate governance, shareholders, directors, compensation, Mistras Group

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.